ABBOTT MOLECULAR INC.

Abbott Molecular Inc. specializes in the manufacturing and support of in-vitro diagnostic substances and precision laboratory systems for clinical and public health applications. The company provides reagent kits, consumables, and molecular testing solutions for infectious diseases including SARS-CoV-2, HIV, HCV, HBV, HPV, and transplant-related pathogens, primarily supporting PCR-based platforms such as the Alinity M system. Their technical expertise extends to diagnostic assay development, laboratory supply chain logistics, and the maintenance of high-complexity analytical instrumentation, ensuring continuity of critical testing services in high-volume clinical environments. A key differentiator is their integrated approach combining reagent manufacturing with end-to-end instrument support, enabling seamless deployment of molecular diagnostics in resource-constrained settings. The contractor maintains a dominant presence with the Department of Veterans Affairs, delivering sustained supply chains for infectious disease testing and comprehensive maintenance agreements for diagnostic equipment. They also support the Department of Health and Human Services with specialized food product procurement, indicating a diversified operational footprint beyond diagnostics. The Department of Defense engages them for molecular testing capabilities in military pathology and laboratory services, reflecting trust in their clinical-grade diagnostic reliability. Their primary industry focus is in vitro diagnostic substance manufacturing, with complementary capabilities in analytical laboratory instrument maintenance and precision equipment servicing. This positions them as a vertically integrated provider of molecular diagnostics—from reagent formulation to instrument lifecycle support—serving clinical laboratories, public health networks, and military medical facilities. Abbott Molecular Inc. is a large-scale manufacturer headquartered in Des Plaines, Illinois, operating under a 2L corporate structure. While no federal certifications are listed, their consistent performance across high-regulation healthcare and defense contracts demonstrates alignment with FDA, CLIA, and CAP standards. Their geographic presence supports national distribution of diagnostic solutions with emphasis on federal healthcare infrastructure.